Wall N, Lamerton R, Ashford F, Perez-Toledo M, Jasiulewicz A, Banham G
Vaccines (Basel). 2025; 13(1).
PMID: 39852786
PMC: 11768972.
DOI: 10.3390/vaccines13010007.
Barghash R, Gemmati D, Awad A, Elbakry M, Tisato V, Awad K
Molecules. 2024; 29(23.
PMID: 39683724
PMC: 11643501.
DOI: 10.3390/molecules29235564.
Wang Z, Shi Z, Liao X, Quan G, Dong H, Zhao P
Adv Sci (Weinh). 2024; 11(45):e2402975.
PMID: 39373693
PMC: 11615778.
DOI: 10.1002/advs.202402975.
Lin M, Huang C, Chiu C, Chen C
Vaccines (Basel). 2024; 12(9).
PMID: 39340088
PMC: 11435596.
DOI: 10.3390/vaccines12091057.
Muraoka D, Moi M, Muto O, Nakatsukasa T, Deng S, Takashima C
NPJ Vaccines. 2024; 9(1):173.
PMID: 39294173
PMC: 11411095.
DOI: 10.1038/s41541-024-00961-6.
Insights into structural vaccinology harnessed for universal coronavirus vaccine development.
Lim C, Leow C, Lim H, Kok B, Chuah C, Oliveira J
Clin Exp Vaccine Res. 2024; 13(3):202-217.
PMID: 39144127
PMC: 11319108.
DOI: 10.7774/cevr.2024.13.3.202.
Dynamic clade transitions and the influence of vaccination on the spatiotemporal circulation of SARS-CoV-2 variants.
Banho C, de Carvalho Marques B, Sacchetto L, Lima A, Parra M, Lima A
NPJ Vaccines. 2024; 9(1):145.
PMID: 39127725
PMC: 11316783.
DOI: 10.1038/s41541-024-00933-w.
Weak Value Amplification Based Optical Sensor for High Throughput Real-Time Immunoassay of SARS-CoV-2 Spike Protein.
Zhang X, Zhang L, Li H, Xu Y, Meng L, Liang G
Biosensors (Basel). 2024; 14(7).
PMID: 39056608
PMC: 11274545.
DOI: 10.3390/bios14070332.
Recent approaches in computational modelling for controlling pathogen threats.
Lees J, Russell T, Shaw L, Hellewell J
Life Sci Alliance. 2024; 7(9).
PMID: 38906676
PMC: 11192964.
DOI: 10.26508/lsa.202402666.
Human cytokine and coronavirus nucleocapsid protein interactivity using large-scale virtual screens.
Tomezsko P, Ford C, Meyer A, Michaleas A, Jaimes 3rd R
Front Bioinform. 2024; 4:1397968.
PMID: 38855143
PMC: 11157076.
DOI: 10.3389/fbinf.2024.1397968.
Innovations and Challenges in the Development of COVID-19 Vaccines for a Safer Tomorrow.
Kumar D, Prasanth K, Bhandari A, Kumar Jha V, Naveen A, Prasanna M
Cureus. 2024; 16(5):e60015.
PMID: 38854201
PMC: 11162516.
DOI: 10.7759/cureus.60015.
Modeling and predicting individual variation in COVID-19 vaccine-elicited antibody response in the general population.
Nakamura N, Kobashi Y, Kim K, Park H, Tani Y, Shimazu Y
PLOS Digit Health. 2024; 3(5):e0000497.
PMID: 38701055
PMC: 11068210.
DOI: 10.1371/journal.pdig.0000497.
Validation and Suitability Assessment of Multiplex Mesoscale Discovery Immunogenicity Assay for Establishing Serological Signatures Using Vaccinated, Non-Vaccinated and Breakthrough SARS-CoV-2 Infected Cases.
Shengule S, Alai S, Bhandare S, Patil S, Gautam M, Mangaonkar B
Vaccines (Basel). 2024; 12(4).
PMID: 38675815
PMC: 11053742.
DOI: 10.3390/vaccines12040433.
Whole-Genome Sequencing and Mutation Analyses of SARS-CoV-2 Isolates from Indonesia.
Oktavianthi S, Lages A, Kusuma R, Kurniasih T, Trimarsanto H, Andriani F
Pathogens. 2024; 13(4).
PMID: 38668234
PMC: 11053823.
DOI: 10.3390/pathogens13040279.
A Longitudinal Study in Tunisia to Assess the Anti-RBD IgG and IgA Responses Induced by Three Different COVID-19 Vaccine Platforms.
Ben Hamouda W, Hanachi M, Ben Hamouda S, Kammoun Rebai W, Gharbi A, Baccouche A
Trop Med Infect Dis. 2024; 9(3).
PMID: 38535885
PMC: 10975151.
DOI: 10.3390/tropicalmed9030061.
COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination history.
Townsley H, Gahir J, Russell T, Greenwood D, Carr E, Dyke M
PLoS One. 2024; 19(3):e0294897.
PMID: 38512960
PMC: 10956747.
DOI: 10.1371/journal.pone.0294897.
Path analysis of perceived disease vulnerability, COVID-19 fear, and lower vaccine hesitancy within the context of protection motivation theory.
Bok S, Shum J, Lee M
Heliyon. 2024; 10(4):e25889.
PMID: 38390175
PMC: 10881856.
DOI: 10.1016/j.heliyon.2024.e25889.
Dynamic clade transitions and the influence of vaccine rollout on the spatiotemporal circulation of SARS-CoV-2 variants in São Paulo, Brazil.
Banho C, de Carvalho Marques B, Sacchetto L, Lima A, Parra M, Lima A
Res Sq. 2024; .
PMID: 38343798
PMC: 10854302.
DOI: 10.21203/rs.3.rs-3788142/v1.
Combined analyses of within-host SARS-CoV-2 viral kinetics and information on past exposures to the virus in a human cohort identifies intrinsic differences of Omicron and Delta variants.
Russell T, Townsley H, Abbott S, Hellewell J, Carr E, Chapman L
PLoS Biol. 2024; 22(1):e3002463.
PMID: 38289907
PMC: 10826969.
DOI: 10.1371/journal.pbio.3002463.
Computational Modeling Insights into Extreme Heterogeneity in COVID-19 Nasal Swab Data.
Zhang L, Cao H, Medlin K, Pearson J, Aristotelous A, Chen A
Viruses. 2024; 16(1).
PMID: 38257769
PMC: 10820884.
DOI: 10.3390/v16010069.
